Michael Manganiello, FOUNDING PARTNERA born advocate, Michael Manganiello believes in the power of patient groups to impact major shifts in health policy. That power is amplified when groups unite around a common agenda. Michael founded HCM with Kristin Conklin and Terrell Halaska as a firm that not only can access major stakeholders in the health care community but can bring them together and find common ground to advance positive change. Michael is driven by this philosophy in his management of the firm’s health policy practice, where he leads the firm’s work for the Christopher and Dana Reeve Foundation, Novo Nordisk, Faster Cures and the New York Stem Cell Foundation.
Michael traveled a deeply personal path to a career in health policy. After earning a bachelor’s degree in political science from Villanova University and a master’s degree in public administration from Columbia University, Michael remained in New York City and became involved in HIV/AIDS advocacy during a time of tremendous fear and uncertainty surrounding the disease. During that time, he also developed a lasting friendship with a woman named Dana Morosini, later Dana Reeve, the wife of Christopher Reeve.
After Christopher Reeve’s equestrian accident that left him paralyzed, the Reeves put Michael’s dedication and passion for patient advocacy to work. They tapped him as senior vice president of government relations for the Christopher and Dana Reeve Foundation, where he played an integral role in establishing the foundation as a leading force for advancing medical research. Among his successes, Michael authored and secured introduction of the Christopher Reeve Paralysis Act – which became law in 2009 – and raised $22.5 million for the Christopher and Dana Reeve Paralysis Resource Center.
Michael brings to HCM an impressive track record of building effective coalitions within the health care community. He chaired the Paralysis Task Force, which collaborated with the Centers for Disease Control and Prevention and the Hope Network to connect more than 50,000 advocates across the country. He is also a founding member, president emeritus, and board member of the Coalition for the Advancement of Medical Research (CAMR), which unites more than 100 diverse organizations in support of groundbreaking medical research. He and CAMR were instrumental in Congress’ passage of the Stem Cell Research Enhancement Act and the Administration’s decision to allow federal funding for embryonic stem cell research.
Michael has served on several boards and advisory panels, including the National Institutes of Health (NIH) Director’s Council of Public Representatives, the National Association for Biomedical Research, the Prevent Cancer Foundation, and the National Symposium on Health Care Reform. He is passionate about his role as a board member of Whitman Walker Health, the largest provider of HIV/AIDS health services in Washington, D.C. and has a strong focus on LGBT health issues. Whitman Walker, a Federally Qualified Health Center, is the new and better entry point for many Americans to receive their health care. It is at the center of the innovative changes that the Affordable Care Act exemplifies. Michael lives in Washington, D.C. in the vibrant Logan Circle neighborhood.